No data to
display.
Tracon Pharmaceuticals, Inc. posted revenue of 626 K
Published on Jul 30, 2022 | 02:30 AM IST
Tracon Pharmaceuticals, Inc. [TCON]
As of May 10, 2017| Source: Quarterly Report to the SEC
We are a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing our cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States.
| Industry | Manufacturing |
| Revenue | 626 K |
| Profits | -7147 K |